Patents by Inventor Lone Bruun

Lone Bruun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
    Patent number: 9610287
    Abstract: The present invention relates to 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof with activity at dopamine D1 and D2 receptors as well as the serotonin 5HT2 receptor for the treatment of diseases in the central nervous system in a once weekly dosing regime.
    Type: Grant
    Filed: June 20, 2012
    Date of Patent: April 4, 2017
    Assignee: H. Lundbeck A/S
    Inventors: René Holm, Lone Bruun
  • Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
    Publication number: 20140194409
    Abstract: The present invention relates to 4-((1R,3S)-6-chloro-3-phenyl-indan-1yl)-1,2,2-trimethyl-piperazine and the salts thereof with activity at dopamine D1 and D2 receptors as well as the serotonin 5HT2 receptor for the treatment of diseases in the central nervous system in a once weekly dosing regime.
    Type: Application
    Filed: June 20, 2012
    Publication date: July 10, 2014
    Applicant: H. Lundbeck A/S
    Inventors: René Holm, Lone Bruun
  • Method for treating cognitive deficits
    Publication number: 20110207744
    Abstract: The invention relates to methods of treating cognitive dysfunction and improving cognitive functioning comprising the administration of trans-4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a pharmaceutically acceptable salt thereof to a patient in need thereof. Moreover the invention relates to an improved binder in a composition comprising 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine.
    Type: Application
    Filed: May 5, 2011
    Publication date: August 25, 2011
    Applicant: H. Lundbeck A/S
    Inventors: Christina Kurre Olsen, Rene Holm, Christine Kau, Birgitte Willumsen, Klaus Peter Hertel, Lone Bruun, Karina Krojer Soby
  • Oral Formulation
    Publication number: 20110178094
    Abstract: The invention relates to a pharmaceutical composition intended for oral administration comprising low doses of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and to a composition comprising the compound.
    Type: Application
    Filed: October 1, 2009
    Publication date: July 21, 2011
    Applicant: H. LUNDBECK A/S
    Inventors: Rene Holm, Christine Kau, Birgitte Willumsen, Klaus Peter Hertel, Christina Kurre Olsen, Lone Bruun, Karina Krojer Soby
  • METHOD FOR TREATING COGNITIVE DEFICITS
    Publication number: 20090306092
    Abstract: The invention relates to methods of treating cognitive dysfunction and improving cognitive functioning comprising the administration of trans-4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a pharmaceutically acceptable salt thereof to a patient in need thereof. Moreover the invention relates to an improved binder in a composition comprising 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine.
    Type: Application
    Filed: May 7, 2009
    Publication date: December 10, 2009
    Applicant: H. Lundbeck A/S
    Inventors: Christina Kurre Olsen, Rene Holm, Christine Kau, Birgitte Willumsen, Klaus peter Hertel, Lone Bruun, Karina Krojer Soby